Literature DB >> 30352146

Process Design and Optimization in the Pharmaceutical Industry: A Suzuki-Miyaura Procedure for the Synthesis of Savolitinib.

Neil K Adlington1, Lauren R Agnew1, Andrew D Campbell1, Robert J Cox1, Andrew Dobson1, Cristina Fernandez Barrat1, Malcolm A Y Gall1, William Hicks1, Gareth P Howell1, Anna Jawor-Baczynska1, Lucie Miller-Potucka1, Michael Pilling1, Katy Shepherd1, Ross Tassone1, Brian A Taylor1, Aled Williams1.   

Abstract

A multidisciplinary approach covering synthetic, physical, and analytical chemistry, high-throughput experimentation and experimental design, process engineering, and solid-state chemistry is used to develop a large-scale (kilomole) Suzuki-Miyaura process. Working against clear criteria and targets, a full process investigation and optimization package is described highlighting how and why key decisions are made in the development of large-scale pharmaceutical processes.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30352146     DOI: 10.1021/acs.joc.8b02351

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

1.  Ultra-High-Throughput Acoustic Droplet Ejection-Open Port Interface-Mass Spectrometry for Parallel Medicinal Chemistry.

Authors:  Kenneth J DiRico; Wenyi Hua; Chang Liu; Joseph W Tucker; Anokha S Ratnayake; Mark E Flanagan; Matthew D Troutman; Mark C Noe; Hui Zhang
Journal:  ACS Med Chem Lett       Date:  2020-05-01       Impact factor: 4.345

Review 2.  Syntheses and Applications of 1,2,3-Triazole-Fused Pyrazines and Pyridazines.

Authors:  Gavin R Hoffman; Allen M Schoffstall
Journal:  Molecules       Date:  2022-07-22       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.